Connect with us
Roche is set to acquire Carmot Therapeutics, along with three clinical-stage assets for treating obesity and diabetes, for a maximum of €2.85 billion. The agreement involves...
In markets we face risk constantly. Trying to figure out what the risks are and where we are in the cycle is the hard part. This...
Startups that go on to billion-dollar-plus valuations are what we call unicorns. However, this name misses that their formula for success is usually double-pronged, capitalizing on...